Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_000018.4:c.1077+2T>A

CA397724300

Gene: ACADVL

Condition: very long chain acyl-CoA dehydrogenase deficiency

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: d250c95e-c88d-4ac1-9506-1284b154c09b

HGVS expressions

NM_000018.4:c.1077+2T>A

NC_000017.11:g.7222867T>A

CM000679.2:g.7222867T>A

NC_000017.10:g.7126186T>A

CM000679.1:g.7126186T>A

NC_000017.9:g.7066910T>A

NG_007975.1:g.8034T>A

NG_008391.2:g.2184A>T

ENST00000356839.10:c.1077+2T>A

ENST00000322910.9:c.*1032+2T>A

ENST00000350303.9:c.1011+2T>A

ENST00000356839.9:c.1077+2T>A

ENST00000543245.6:c.1146+2T>A

ENST00000578824.5:n.228T>A

ENST00000582379.1:n.463T>A

ENST00000583858.5:n.106+2T>A

ENST00000585203.6:n.20T>A

NM_000018.3:c.1077+2T>A

NM_001033859.2:c.1011+2T>A

NM_001270447.1:c.1146+2T>A

NM_001270448.1:c.849+2T>A

NM_001033859.3:c.1011+2T>A

NM_001270447.2:c.1146+2T>A

NM_001270448.2:c.849+2T>A

Pathogenic

PP4_Moderate PVS1 PM2_Supporting

PP3

Evidence Links 0

Expert Panel

ACADVL VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

ACADVL VCEP

The c.1077+2T>A (NM_000018.4) variant in ACADVL occurs within the canonical splice donor site (+/- 1,2) of intron 10. It is predicted to cause skipping of biologically-relevant-exon 10/20, resulting in a frameshift leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1: PMIDs 9973285, 11590124). This variant been reported in one individual with very long chain acyl-CoA dehydrogenase deficiency in the literature with decreased VLCAD enzyme activity (PP4_moderate; PMID: 30194637). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The ACADVL Variant Curation Expert Panel VCEP classified the variant as pathogenic based on PVS1, PM2_supporting, PP4_Moderate.

PP4_Moderate

One proband displays 8% VLCAD residual activity, less than the required 20% for PP4_moderate

PVS1

This splice-site variant is predicted to break the wild-type donor site, leading to Exon 10 skipping and a resulting frameshift that creates a termination codon in Exon 11 well before the penultimate exon. Therefore, this is predicted to undergo NMD and meets PVS1.

PM2_Supporting

Not in gnomAD

PP3

Not used for canonical splice-site variants meeting PVS1

Approved on: 2022-09-22

Published on: 2022-09-22

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.